Annovis Historical Valuation

ANVS
 Stock
  

USD 12.20  0.93  8.25%   

Some fundamental drivers such as market cap or Annovis Bio enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Annovis Bio valuation indicators such as Average Equity of 38.8 M or Enterprise Value of 89.9 M to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Annovis Bio's future value. Financial Statement Analysis is much more than just reviewing and breaking down Annovis Bio prevalent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Annovis Bio is a good buy for the upcoming year.
Please continue to Trending Equities.
  
Refresh
Share

About Annovis Valuation Data Analysis

Valuation is the financial process of determining what Annovis Bio is worth. Annovis Bio valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Annovis Bio valuation ratios help investors to determine whether Annovis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Annovis with respect to the benefits of owning Annovis Bio security.

Annovis Bio Valuation Data Chart

Annovis valuation ratios help to determine how cheap or expensive it is, compared to its peers or based on some benchmark measure of value for a given date. A typical valuation ratio shows the difference between the cost of Annovis equity instrument and the benefits of owning shares of Annovis Bio.
Annovis Bio Tangible Asset Value is relatively stable at the moment as compared to the past year. Annovis Bio reported last year Tangible Asset Value of 46 Million. As of 06/27/2022, Working Capital is likely to grow to about 48 M, while Earnings Before Interest Taxes and Depreciation Amortization EBITDA are likely to drop (14.9 M).

Average Assets

Average asset value for the period used in calculation of Return on Average Equity and Return on Average Assets; derived from Total Assets.

Earnings Before Interest Taxes and Depreciation Amortization USD

Earnings Before Interest Taxes and Depreciation Amortization EBITDA in USD; converted by US Dollar Exchange Rate.

Enterprise Value

Enterprise Value (or EV) is usually referred to as Annovis Bio theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Annovis Bio debt, but would also pocket its cash. Enterprise Value is more accurate representation of Annovis Bio value than its market capitalization because it takes into account all of Annovis Bio existing debt. Enterprise value is a measure of the value of a business as a whole; calculated as Market Capitalization plus Total Debt USD minus Cash and Equivalents USD.

Market Capitalization

Market capitalization (or market cap) is the total value of the shares outstanding of Annovis Bio. It is equal to Annovis Bio current share price times the number of Annovis Bio outstanding shares. Represents the product of [SharesBas]; [Price] and [ShareFactor].
Most indicators from Annovis Bio valuation accounts are interrelated and interconnected. However, analyzing valuation accounts indicators one by one will only give a small insight into Annovis Bio current financial condition. On the other hand, looking into the entire matrix of valuation accounts indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please continue to Trending Equities.Annovis Bio Tangible Asset Value is relatively stable at the moment as compared to the past year. Annovis Bio reported last year Tangible Asset Value of 46 Million. As of 06/27/2022, Working Capital is likely to grow to about 48 M, while Earnings Before Interest Taxes and Depreciation Amortization EBITDA are likely to drop (14.9 M).
 2021 2022 (projected)
Tangible Asset Value46 M49.63 M
Market Capitalization142.41 M131.22 M

Annovis Bio valuation accounts Correlations

Annovis Bio Account Relationship Matchups

Be your own money manager

Our tools can tell you how much better you can do entering a position in Annovis Bio without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Technical Analysis Now

   

Technical Analysis

Check basic technical indicators and analysis based on most latest market data
All  Next Launch Module
Please continue to Trending Equities. Note that the Annovis Bio information on this page should be used as a complementary analysis to other Annovis Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for Annovis Stock analysis

When running Annovis Bio price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Is Annovis Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Annovis Bio. If investors know Annovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Annovis Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
92 M
Return On Assets
-0.44
Return On Equity
-0.74
The market value of Annovis Bio is measured differently than its book value, which is the value of Annovis that is recorded on the company's balance sheet. Investors also form their own opinion of Annovis Bio's value that differs from its market value or its book value, called intrinsic value, which is Annovis Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Annovis Bio's market value can be influenced by many factors that don't directly affect Annovis Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Annovis Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Annovis Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Annovis Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.